• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. COBAS MPX TEST, CE-IVD; ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. COBAS MPX TEST, CE-IVD; ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA Back to Search Results
Catalog Number 06997708190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Test Result (2695)
Event Date 02/19/2019
Event Type  Injury  
Manufacturer Narrative
An investigation was performed and no kit issues were identified relating to (b)(6) results.Based on the results generated for this donor, it is suspected that the donor was infected between (b)(6) 2018 and (b)(6) 2019, with a low level (b)(6) infection, which may not consistently be detected by the cobas mpx test, where serology was (b)(6) due to the lack of seroconversion (window period).The cobas mpx test, ce ivd instructions for use indicates "detection of hiv-1 group m rna, hiv-1 group o rna, hiv-2 rna, hcv rna, and hbv dna is dependent on the number of virus particles present in the sample and may be affected by sample collection, storage and handling, patient factors (i.E., age, presence of symptoms), and/or stage of infection and pool size." the material number for the cobas mpx test, 96t, us-ivd is 06998909190.(b)(4).
 
Event Description
A (b)(6) customer alleged the generation of a (b)(6) sample tested with the cobas mpx test for use on the cobas 6800/8800 system ((b)(6) 2019) in pool of 8.As the result in (b)(6) 2019 matched (b)(6) serology results, the donation was released and there are two recipients of this donation.It is confirmed that one patient received the thrombocyte concentrate and is being monitored.There is no information regarding if the second patient received the erythrocyte concentrate.In (b)(6) 2019, the customer received an anonymous call requesting that the donor be drawn and tested again.A new donation and previous donations from (b)(6) 2019 and (b)(6) 2018 were tested in (b)(6) 2019.The new donation and the donation from (b)(6) 2019 generated (b)(6) results and the donation from (b)(6) 2018 generated (b)(6) results.The serology for this donor was (b)(6).
 
Manufacturer Narrative
Na.
 
Event Description
(b)(6) 2019, it was indicated that the second recipient received the erythrocyte concentration; this information was unknown at the time of filing the initial mdr report.Additionally, it was noted that both recipients have a viral load of 6.8-7*10^6 iu/ml, but it is unclear what test method was used to test the recipients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS MPX TEST, CE-IVD
Type of Device
ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC.
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key8634629
MDR Text Key145915319
Report Number2243471-2019-00021
Device Sequence Number1
Product Code MZP
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup
Report Date 08/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Catalogue Number06997708190
Device Lot NumberE10866
Initial Date Manufacturer Received 05/02/2019
Initial Date FDA Received05/22/2019
Supplement Dates Manufacturer Received05/02/2019
Supplement Dates FDA Received08/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-